Evaluation of SARS-CoV-2 RNA quantification by RT-LAMP compared to RT-qPCR.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 06 02 2021
revised: 19 04 2021
accepted: 06 05 2021
pubmed: 20 5 2021
medline: 25 6 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral load of SARS-CoV-2 is associated with mortality in COVID-19 patients. Measurement of viral load requires the use of reverse transcription quantitative PCR (RT-qPCR), which in turn requires advanced equipment and techniques. In this study, we aimed to evaluate the viral load measurement using reverse transcription loop-mediated isothermal amplification (RT-LAMP), which is a simpler procedure compared to RT-qPCR. RNA was extracted by using the QIAamp Viral RNA Mini Kit. The RT-LAMP assay was performed by using the Loopamp® 2019-SARS-CoV-2 detection reagent kit and 10-fold serial dilutions of known viral load RT-LAMP were used to measure Tt, which is the time until the turbidity exceeds the threshold. Based on the relationship between viral load and Tt, the linearity and detection sensitivity of the calibration curve were evaluated. In addition, 117 clinical specimens were measured, and RT-qPCR and RT-LAMP assay results were compared. The dilution linearity of the calibration curve was maintained at five orders of magnitude 1.0× 10 The findings indicate that RT-LAMP is an effective method to determine the viral load of SARS-CoV-2.

Identifiants

pubmed: 34006453
pii: S1341-321X(21)00133-1
doi: 10.1016/j.jiac.2021.05.004
pmc: PMC8112399
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1068-1071

Informations de copyright

Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

Kenta Minami (K)

Department of Central Clinical Laboratory, Osaka Medical College Hospital, Osaka, Japan; Infection Control Center, Osaka Medical College Hospital, Osaka, Japan. Electronic address: kns133@osaka-med.ac.jp.

Ryota Masutani (R)

Department of Central Clinical Laboratory, Osaka Medical College Hospital, Osaka, Japan.

Youichi Suzuki (Y)

Infection Control Center, Osaka Medical College Hospital, Osaka, Japan; Department of Microbiology and Infection Control, Osaka Medical College, Osaka, Japan.

Meri Kubota (M)

Department of Central Clinical Laboratory, Osaka Medical College Hospital, Osaka, Japan.

Naofumi Osaka (N)

Department of Central Clinical Laboratory, Osaka Medical College Hospital, Osaka, Japan.

Toyofumi Nakanishi (T)

Infection Control Center, Osaka Medical College Hospital, Osaka, Japan; Department of Clinical and Laboratory Medicine, Osaka Medical College, Osaka, Japan.

Takashi Nakano (T)

Infection Control Center, Osaka Medical College Hospital, Osaka, Japan; Department of Microbiology and Infection Control, Osaka Medical College, Osaka, Japan.

Akira Ukimura (A)

Department of Central Clinical Laboratory, Osaka Medical College Hospital, Osaka, Japan; Infection Control Center, Osaka Medical College Hospital, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH